
Lourdes Ibañez Toda
Research group
Lourdes Ibáñez Toda graduated in Medicine in 1977 from the Autonomous University of Barcelona and received her Doctor of Medicine degree from the Autonomous University of Barcelona in 1981.
From 1993 to 1994 she spent a stay at Massachusetts General Hospital in Boston where she studied the mechanisms involved in the pathophysiology of polycystic ovary. She has subsequently developed international collaborations with a number of European (Belgium, Germany, United Kingdom) and US groups working on the subject which have resulted in numerous publications in impact factor journals (H 55 Index) and guest presentations, and in a consensus text on the pathophysiology, diagnosis, and treatment of polycystic ovary syndrome in adolescents (2017).
The trajectory was recognized with the Research Award (2013), awarded by the European Society for Paediatric Endocrinology (ESPE), and with the National Research Award (2014), granted by the Catalan Foundation for Research and Innovation (Generalitat de Catalunya). Lourdes Ibáñez is also coordinator of the Paediatric & Adolescent Working Group of the ESPE, and of the study group of the Small for the Gestational Age, of the Spanish Society of Pediatric Endocrinology, and leader of the CIBERDEM group (Carlos III Health Institute, Madrid).
Since 2012 she has been a full professor at the University of Barcelona (UB), director of the master's degree in endocrinology and diabetes of the child and adolescent of the UB, and since 2016 head of clinical research at the endocrinology service. She is currently coordinating the research area at the IRSJD on "Adaptive response, metabolism and immunobiology”.
Professional network profiles
Related websites
Last Publications
- Xargay S, Mas-Parés B, Carreras-Badosa G, Lizárraga-Mollinedo E, Tibau J, Reixach J, Platero-Gutierrez E, Prats A, de Zegher F, Ibañez-Toda L, Bassols-Casadevall J and López-Bermejo A Metabolic programming in the offspring after gestational overfeeding in the mother: toward neonatal rescuing with metformin in a swine model. INTERNATIONAL JOURNAL OF OBESITY . 46(5): 1018-1026.
- García-Beltran C, Villarroya-Terrade J, Plou C, Gavaldà-Navarro A, Casano-Sancho P, Cereijo R, de Zegher F, López-Bermejo A, Ibañez-Toda L and Villarroya-Gombau F Bone Morphogenetic Protein-8B Levels at Birth and in the First Year of Life: Relation to Metabolic-Endocrine Variables and Brown Adipose Tissue Activity. Frontiers in pediatrics . 10: 869581-869581.
- García-Beltran C, Cereijo R, Plou C, Gavaldà-Navarro A, Malpique R, Villarroya-Terrade J, López-Bermejo A, de Zegher F, Ibañez-Toda L and Villarroya-Gombau F Posterior Cervical Brown Fat and CXCL14 Levels in the First Year of Life: Sex Differences and Association With Adiposity. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM . 107(3): 1148-1158.
Projects
- Project name:
- SPIOMET4HEALTH_PCOS in adolescent girls and young women: Toward a treatment guided by pathopsysiology
- Leader
- Lourdes Ibañez Toda
- Funding entities:
- European Commission
- Code
- 899671
- Starting - finishing date:
- 2021 - 2026
- Project name:
- Subvencions per a la contractació de personal investigador en formació (PIF-Salut). Beneficiari: Cristina García Beltran
- Leader
- Lourdes Ibañez Toda
- Funding entities:
- Departament de Salut - Generalitat de Catalunya
- Code
- SLT017/20/000228
- Starting - finishing date:
- 2021 - 2024
- Project name:
- 2a Accésit de los Premios a la Investigación en Endocrinología Pediátrica y Crecimiento 2020
- Leader
- Lourdes Ibañez Toda
- Funding entities:
- Fundación Sociedad Española de Endocrinología Pediátrica
- Code
- PCP00291
- Starting - finishing date:
- 2020 - 2021
News
-
Brown adipose tissue activity is higher in girls during the first year of life
A team led by Dr Lourdes Ibáñez and Dr Francesc Villarroya, IRSJD researchers, publishes the first study that shows the very early appearance of differences in the activity of the brown adipose tissue between girls and boys.
-
Dr. Lourdes Ibañez coordinates the European SPIOMET4HEALTH project: a new treatment for polycystic ovary syndrome in adolescents and young women
Dr. Lourdes Ibañez, from the Institut de Recerca Sant Joan de Déu, coordinates the new European SPIOMET4HEALTH will test the efficacy of this new treatment for Polycystic Ovary Syndrome (PCOS) in adolescent girls and young adult women, in a multi-centric phase II clinical trial.